1. |
Munn Z, Stern C, Aromataris E, et al. What kind of systematic review should I conduct? A proposed typology and guidance for systematic reviewers in the medical and health sciences. BMC Med Res Methodol, 2018, 18(1): 5.
|
2. |
Moher D, Hopewell S, Schulz KF, et al. CONSORT 2010 explanation and elaboration: Updated guidelines for reporting parallel group randomised trials. BMJ, 2010, 340: c869.
|
3. |
Lasserson TJ, Thomas J, JPT H. Chapter 1: Starting a review. In: Higgins JPT, Thomas J, Chandler J, et al (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023): Cochrane. 2023.
|
4. |
Kakkos SK, Vega de Ceniga M, Naylor R. A systematic review and meta-analysis of peri-procedural outcomes in patients undergoing carotid interventions following thrombolysis. Eur J Vasc Endovasc Surg, 2021, 62(3): 340-349.
|
5. |
Schmidt LM, Gøtzsche PC. Of mites and men: Reference bias in narrative review articles. J Fam Pract, 2005, 54(4): 334-338.
|
6. |
Easterbrook PJ, Berlin JA, Gopalan R, et al. Publication bias in clinical research. Lancet, 1991, 337(8746): 867-872.
|
7. |
Crowther M, Lim W, Crowther MA. Systematic review and meta-analysis methodology. Blood, 2010, 116(17): 3140-3146.
|
8. |
Higgins JP. Cochrane handbook for systematic reviews of interventions version 5.0.1. The Cochrane Collaboration, 2008. Accessed on 2024-05-10.
|
9. |
Higgins JP, Altman DG, Gøtzsche PC, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ, 2011, 343: d5928.
|
10. |
Sterne JAC, Savović J, Page MJ, et al. RoB 2: A revised tool for assessing risk of bias in randomised trials. BMJ, 2019, 366: l4898.
|
11. |
Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol, 2010, 25(9): 603-605.
|
12. |
Lohr KN, Carey TS. Assessing "best evidence": Issues in grading the quality of studies for systematic reviews. Jt Comm J Qual Improv, 1999, 25(9): 470-479.
|
13. |
Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Ann Intern Med, 2009, 151(4): 264-269.
|
14. |
Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ, 2021, 372: n71.
|
15. |
Nederkoorn PJ, Mali WP, Eikelboom BC, et al. Preoperative diagnosis of carotid artery stenosis: Accuracy of noninvasive testing. Stroke, 2002, 33(8): 2003-2008.
|
16. |
Takwoingi Y, Dendukuri N, Schiller I, et al. Chapter 10: Undertaking meta-analysis. In: Deeks JJ, Bossuyt PM, Leeflang MM, et al (editors). Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy. Version 2.0 (updated July 2023): Cochrane. 2023.
|
17. |
Whiting PF, Rutjes AW, Westwood ME, et al. QUADAS-2: A revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med, 2011, 155(8): 529-536.
|
18. |
Deeks JJ, Bossuyt PM, Leeflang MM, et al. Cochrane handbook for systematic reviews of diagnostic test accuracy. John Wiley & Sons, 2023.
|
19. |
McInnes MDF, Moher D, Thombs BD, et al. Preferred reporting items for a systematic review and meta-analysis of diagnostic test accuracy studies: The PRISMA-DTA statement. JAMA, 2018, 319(4): 388-396.
|
20. |
Chaimani ACD, Li T, Higgins JPT, et al. Chapter 11: Undertaking network meta-analyses. In: Higgins JPT, Thomas J, Chandler J, et al, (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). Cochrane, 2023.
|
21. |
Lu G, Ades AE. Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med, 2004, 23(20): 3105-3124.
|
22. |
Caldwell DM, Ades AE, Higgins JP. Simultaneous comparison of multiple treatments: Combining direct and indirect evidence. BMJ, 2005, 331(7521): 897-900.
|
23. |
White IR. Network meta-analysis. Stata J, 2015, 15(4): 951-985.
|
24. |
Aiolfi A, Nosotti M, Micheletto G, et al. Pulmonary lobectomy for cancer: Systematic review and network meta-analysis comparing open, video-assisted thoracic surgery, and robotic approach. Surgery, 2021, 169(2): 436-446.
|
25. |
Leucht S, Chaimani A, Cipriani AS, et al. Network meta-analyses should be the highest level of evidence in treatment guidelines. Eur Arch Psychiatry Clin Neurosci, 2016, 266(6): 477-480.
|
26. |
Cooper NJ, Peters J, Lai MC, et al. How valuable are multiple treatment comparison methods in evidence-based health-care evaluation? Value Health, 2011, 14(2): 371-380.
|
27. |
Li T, Puhan MA, Vedula SS, et al. Network meta-analysis-highly attractive but more methodological research is needed. BMC Med, 2011, 9: 79.
|
28. |
Song F, Loke YK, Walsh T, et al. Methodological problems in the use of indirect comparisons for evaluating healthcare interventions: Survey of published systematic reviews. BMJ, 2009, 338: b1147.
|
29. |
Salanti G, Marinho V, Higgins JP. A case study of multiple-treatments meta-analysis demonstrates that covariates should be considered. J Clin Epidemiol, 2009, 62(8): 857-864.
|
30. |
Song F, Harvey I, Lilford R. Adjusted indirect comparison may be less biased than direct comparison for evaluating new pharmaceutical interventions. J Clin Epidemiol, 2008, 61(5): 455-463.
|
31. |
Salanti G. Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: Many names, many benefits, many concerns for the next generation evidence synthesis tool. Res Synth Methods, 2012, 3(2): 80-97.
|
32. |
Smith TC, Spiegelhalter DJ, Thomas A. Bayesian approaches to random-effects meta-analysis: A comparative study. Stat Med, 1995, 14(24): 2685-2699.
|
33. |
Lunn DJ, Thomas A, Best N, et al. WinBUGS-a Bayesian modelling framework: Concepts, structure, and extensibility. Stat Comput, 2000, 10: 325-337.
|
34. |
Röver C. Bayesian random-effects meta-analysis using the bayesmeta R package. J Stat Softw, 2020, 93: 1-51.
|
35. |
Bucher HC, Guyatt GH, Griffith LE, et al. The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. J Clin Epidemiol, 1997, 50(6): 683-691.
|
36. |
van Valkenhoef G, Dias S, Ades AE, et al. Automated generation of node-splitting models for assessment of inconsistency in network meta-analysis. Res Synth Methods, 2016, 7(1): 80-93.
|
37. |
Salanti G, Ades AE, Ioannidis JP. Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: An overview and tutorial. J Clin Epidemiol, 2011, 64(2): 163-171.
|
38. |
Chaimani A, Higgins JP, Mavridis D, et al. Graphical tools for network meta-analysis in STATA. PLoS One, 2013, 8(10): e76654.
|
39. |
Mavridis D, Welton NJ, Sutton A, et al. A selection model for accounting for publication bias in a full network meta-analysis. Stat Med, 2014, 33(30): 5399-5412.
|
40. |
Hutton B, Salanti G, Caldwell DM, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: Checklist and explanations. Ann Intern Med, 2015, 162(11): 777-784.
|
41. |
Belbasis L, Bellou V, Ioannidis JPA. Conducting umbrella reviews. BMJ Med, 2022, 1(1): e000071.
|
42. |
Ioannidis JP. Integration of evidence from multiple meta-analyses: A primer on umbrella reviews, treatment networks and multiple treatments meta-analyses. CMAJ, 2009, 181(8): 488-493.
|
43. |
de Bont J, Jaganathan S, Dahlquist M, et al. Ambient air pollution and cardiovascular diseases: An umbrella review of systematic reviews and meta-analyses. J Intern Med, 2022, 291(6): 779-800.
|
44. |
Biondi-Zoccai G, Versaci F, Iskandrian AE, et al. Umbrella review and multivariate meta-analysis of diagnostic test accuracy studies on hybrid non-invasive imaging for coronary artery disease. J Nucl Cardiol, 2020, 27(5): 1744-1755.
|
45. |
Marano L, Fusario D, Savelli V, et al. Robotic versus laparoscopic gastrectomy for gastric cancer: An umbrella review of systematic reviews and meta-analyses. Updates Surg, 2021, 73(5): 1673-1689.
|
46. |
Fusar-Poli P, Radua J. Ten simple rules for conducting umbrella reviews. Evid Based Ment Health, 2018, 21(3): 95-100.
|
47. |
Pollock M, Fernandes RM, Becker LA, et al. What guidance is available for researchers conducting overviews of reviews of healthcare interventions? A scoping review and qualitative metasummary. Syst Rev, 2016, 5(1): 190.
|
48. |
Pollock M, Fernandes RM, Becker LA, et al. Chapter V: Overviews of reviews. In: Higgins JPT, Thomas J, Chandler J, et al (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023): Cochrane, 2023.
|
49. |
Aromataris E, Fernandez R, Godfrey CM, et al. Summarizing systematic reviews: Methodological development, conduct and reporting of an umbrella review approach. Int J Evid Based Healthc, 2015, 13(3): 132-140.
|
50. |
Shea BJ, Reeves BC, Wells G, et al. AMSTAR 2: A critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ, 2017, 358: j4008.
|
51. |
Cates CJ, Oleszczuk M, Stovold E, et al. Safety of regular formoterol or salmeterol in children with asthma: An overview of Cochrane reviews. Cochrane Database Syst Rev, 2012, 10(10): CD010005.
|
52. |
Shea BJ, Grimshaw JM, Wells GA, et al. Development of AMSTAR: A measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol, 2007, 7: 10.
|
53. |
Whiting P, Savović J, Higgins JP, et al. ROBIS: A new tool to assess risk of bias in systematic reviews was developed. J Clin Epidemiol, 2016, 69: 225-234.
|
54. |
Ballard M, Montgomery P. Risk of bias in overviews of reviews: A scoping review of methodological guidance and four-item checklist. Res Synth Methods, 2017, 8(1): 92-108.
|
55. |
Montgomery DC. Design and analysis of experiments. John wiley & sons, 2017.
|
56. |
Guyatt GH, Oxman AD, Vist GE, et al. GRADE: An emerging consensus on rating quality of evidence and strength of recommendations. BMJ, 2008, 336(7650): 924-926.
|
57. |
Biondi-Zoccai G. Umbrella reviews. Evidence synthesis with overviews of reviews and meta-epidemiologic studies Cham, Switzerland: Springer International, 2016.
|
58. |
Catalá-López F, Stevens A, Garritty C, et al. Rapid reviews for evidence synthesis. Med Clin (Barc), 2017, 148(9): 424-428.
|
59. |
Garritty C, Gartlehner G, Nussbaumer-Streit B, et al. Cochrane Rapid Reviews Methods Group offers evidence-informed guidance to conduct rapid reviews. J Clin Epidemiol, 2021, 130: 13-22.
|
60. |
Hamel C, Michaud A, Thuku M, et al. Defining rapid reviews: A systematic scoping review and thematic analysis of definitions and defining characteristics of rapid reviews. J Clin Epidemiol, 2021, 129: 74-85.
|
61. |
Fønhus MS, Dalsbø TK. Heart surgery of severe rheumatic heart disease–A rapid review. Folkehelseinstituttet, 2021.
|
62. |
Ganann R, Ciliska D, Thomas H. Expediting systematic reviews: Methods and implications of rapid reviews. Implement Sci, 2010, 5: 56.
|
63. |
Tricco AC, Straus SE, Ghaffar A, et al. Rapid reviews for health policy and systems decision-making: More important than ever before. Syst Rev, 2022, 11(1): 153.
|
64. |
Langlois EV, Straus SE, Antony J, et al. Using rapid reviews to strengthen health policy and systems and progress towards universal health coverage. BMJ Glob Health, 2019, 4(1): e001178.
|
65. |
Kovoor JG, Scott NA, Tivey DR, et al. Proposed delay for safe surgery after COVID-19. ANZ J Surg, 2021, 91(4): 495-506.
|
66. |
Grant MJ, Booth A. A typology of reviews: An analysis of 14 review types and associated methodologies. Health Info Libr J, 2009, 26(2): 91-108.
|
67. |
Klerings I, Robalino S, Booth A, et al. Rapid reviews methods series: Guidance on literature search. BMJ Evid Based Med, 2023, 28(6): 412-417.
|
68. |
Preston L, Turner J, Booth A, et al. Is there a relationship between surgical case volume and mortality in congenital heart disease services? A rapid evidence review. BMJ Open, 2015, 5(12): e009252.
|
69. |
Garritty C, Hamel C, Trivella M, et al. Updated recommendations for the Cochrane rapid review methods guidance for rapid reviews of effectiveness. BMJ, 2024, 384: e076335.
|
70. |
Colquhoun HL, Levac D, O'Brien KK, et al. Scoping reviews: Time for clarity in definition, methods, and reporting. J Clin Epidemiol, 2014, 67(12): 1291-1294.
|
71. |
Solou M, Ydreos I, Gavra M, et al. Controversies in the surgical treatment of chronic subdural hematoma: A systematic scoping review. Diagnostics (Basel), 2022, 12(9): 2060.
|
72. |
Arksey H, O'malley L. Scoping studies: Towards a methodological framework. Int J Soc Res Method, 2005, 8(1): 19-32.
|
73. |
Gemelli M, Italiano EG, Geatti V, et al. Optimizing safety and success: The advantages of bloodless cardiac surgery. A systematic review and meta-analysis of outcomes in Jehovah's witnesses. Curr Probl Cardiol, 2024, 49(1 Pt B): 102078.
|
74. |
Peters MD, Godfrey CM, Khalil H, et al. Guidance for conducting systematic scoping reviews. Int J Evid Based Healthc, 2015, 13(3): 141-146.
|
75. |
Tricco AC, Lillie E, Zarin W, et al. PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and explanation. Ann Intern Med, 2018, 169(7): 467-473.
|
76. |
喻佳洁, 陕飞, Peter McCulloch, 等. 外科创新技术/器械临床研究方法学—IDEAL框架与推荐系列文章之一: IDEAL框架与推荐介绍. 中国胸心血管外科临床杂志, 2021, 28(2): 131-136.Yu JJ, Shan F, McCulloch P, et al. The methodological framework of surgical innovation: The introduction of IDEAL framework and recommendation. Chin J Clin Thorac Cardiovasc Surg, 2021, 28(2): 131-136.
|
77. |
陕飞, 尹道馨, 李子禹, 等. 外科临床研究方法学指引—IDEAL框架及指南介绍与解读. 中国实用外科杂志, 2020, 40(1): 93-101.Shan F, Yin DX, Li ZY, et al. Methodological guidance for surgical research-introduction and interpretation of the IDEAL framework and recommendations. Chin J Pract Surg, 2020, 40(1): 93-101.
|